Education
About Us
Working with TipRanks
Follow Us
Shandong Weigao Group Medical Polymer Co Ltd Class H (HK:1066)
:1066
RESEARCH TOOLSreports
Total Valuation
Shandong Weigao Group Medical Polymer Co has a market cap or net worth of $24.38B. The enterprise value is HK$189.52B.
Market Cap$24.38B
Enterprise ValueHK$189.52B
Share Statistics
Shandong Weigao Group Medical Polymer Co has 4,522,332,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,522,332,000
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Shandong Weigao Group Medical Polymer Co’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 6.75%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)6.75%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee1.03M
Profits Per Employee200.78K
Employee Count12,719
Asset Turnover0.38
Inventory Turnover2.57
Valuation Ratios
The current PE Ratio of Shandong Weigao Group Medical Polymer Co is 73.73. Shandong Weigao Group Medical Polymer Co’s PEG ratio is 41.45.
PE Ratio73.73
PS Ratio0.00
PB Ratio8.39
Price to Fair Value6.42
Price to FCF188.81
Price to Operating Cash Flow194.79
PEG Ratio41.45
Income Statement
In the last 12 months, Shandong Weigao Group Medical Polymer Co had revenue of 13.09B and earned 2.07B in profits. Earnings per share was 0.46.
Revenue13.09B
Gross Profit6.58B
Operating Income2.39B
Pretax Income2.55B
Net Income2.07B
EBITDA3.14B
Earnings Per Share (EPS)0.46
Cash Flow
In the last 12 months, operating cash flow was 1.02B and capital expenditures 0.00, giving a free cash flow of 1.02B billion.
Operating Cash Flow1.02B
Free Cash Flow1.02B
Free Cash Flow per Share0.23
Dividends & Yields
Shandong Weigao Group Medical Polymer Co pays an annual dividend of HK$0.132, resulting in a dividend yield of 3.69%
Dividend Per ShareHK$0.132
Dividend Yield3.69%
Payout Ratio46.72%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.01
52-Week Price Change23.43%
50-Day Moving Average5.56
200-Day Moving Average4.83
Relative Strength Index (RSI)40.95
Average Volume (3m)9.36M
Important Dates
Shandong Weigao Group Medical Polymer Co upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateMar 26, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend DateJun 02, 2025
Financial Position
Shandong Weigao Group Medical Polymer Co as a current ratio of 3.20, with Debt / Equity ratio of 17.65%
Current Ratio3.20
Quick Ratio2.78
Debt to Market Cap0.03
Net Debt to EBITDA-1.14
Interest Coverage Ratio9.56
Taxes
In the past 12 months, Shandong Weigao Group Medical Polymer Co has paid 391.03M in taxes.
Income Tax391.03M
Effective Tax Rate0.15
Enterprise Valuation
Shandong Weigao Group Medical Polymer Co EV to EBITDA ratio is 47.35, with an EV/FCF ratio of 69.45.
EV to Sales11.37
EV to EBITDA47.35
EV to Free Cash Flow69.45
EV to Operating Cash Flow53.33
Balance Sheet
Shandong Weigao Group Medical Polymer Co has $8.32B in cash and marketable securities with ¥4.19B in debt, giving a net cash position of -$4.13B billion.
Cash & Marketable Securities$8.32B
Total Debt¥4.19B
Net Cash-$4.13B
Net Cash Per Share-$0.91
Tangible Book Value Per Share$4.45
Margins
Gross margin is 49.94%, with operating margin of 18.23%, and net profit margin of 15.79%.
Gross Margin49.94%
Operating Margin18.23%
Pretax Margin19.51%
Net Profit Margin15.79%
EBITDA Margin24.01%
EBIT Margin17.37%
Analyst Forecast
The average price target for Shandong Weigao Group Medical Polymer Co is $5.20, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$5.20
Price Target Upside-3.49% Downside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast-3.09%
EPS Growth Forecast0.67%